Abstract

CTG expansions in DMPK gene, causing myotonic dystrophy type 1 (DM1), are characterized by pronounced somatic instability. A large proportion of variability of somatic instability is explained by expansion size and patient’s age at sampling, while individual-specific differences are attributed to additional factors. The age at onset is extremely variable in DM1, and inversely correlates with the expansion size and individual-specific differences in somatic instability. Three to five percent of DM1 patients carry repeat interruptions and some appear with later age at onset than expected for corresponding expansion size. Herein, we characterized somatic instability of interrupted DMPK expansions and the effect on age at onset in our previously described patients. Repeat-primed PCR showed stable structures of different types and patterns of repeat interruptions in blood cells over time and buccal cells. Single-molecule small-pool PCR quantification of somatic instability and mathematical modeling showed that interrupted expansions were characterized by lower level of somatic instability accompanied by slower progression over time. Mathematical modeling demonstrated that individual-specific differences in somatic instability had greater influence on age at onset in patients with interrupted expansions. Therefore, repeat interruptions have clinical importance for disease course in DM1 patients due to stabilizing effect on DMPK expansions in somatic cells.

Highlights

  • Myotonic dystrophy type 1 (DM1, MIM #160900) is a multisystem disease that affects skeletal muscles, heart, brain, eyes and endocrine system, and has an extremely variable age of disease onset (Harper, 2001)

  • This study reports on the characterization of mutational dynamics of DMPK expanded alleles in somatic cells in DM1 patients carrying repeat interruptions and how this dynamics influences the age at onset

  • The novelty of our study is the finding that repeat interruptions contribute to later appearance of disease symptoms and the mechanism by which they operate is a genetic stabilization of DMPK expansions in somatic cells

Read more

Summary

Introduction

Myotonic dystrophy type 1 (DM1, MIM #160900) is a multisystem disease that affects skeletal muscles, heart, brain, eyes and endocrine system, and has an extremely variable age of disease onset (Harper, 2001). A noticeable feature of some DM1 patients with repeat interruptions described by us (Pešovicet al., 2017) and others (Musova et al, 2009; Botta et al, 2017) was a later age at onset than expected for the corresponding number of CTG repeats These findings have made repeat interruptions a potential genetic modifier of DM1 phenotype, likewise described in spinocerebellar ataxia type 10 (Matsuura et al, 2006)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call